Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Livedo Vasculitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03749577
What this trial is testing

Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Hospital, Grenoble 30
Testing effectiveness (Phase 2)Study completedNCT04388176
What this trial is testing

Cold Challenge With C21 in RP

Who this might be right for
Raynaud PhenomenonSystemic Sclerosis
Vicore Pharma AB 20
Testing effectiveness (Phase 2)Ended earlyNCT04915950
What this trial is testing

Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Pfizer 13
Not applicableStudy completedNCT06291142
What this trial is testing

Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot

Who this might be right for
Systemic SclerosisRaynaud Phenomenon
University of Manchester 112
Not applicableStudy completedNCT00975871
What this trial is testing

Correlation of Genetic Polymorphism and Livedo Vasculitis

Who this might be right for
Livedo VasculitisLivedoid VasculitisLivedoid Vasculopathy+2 more
National Taiwan University Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT02374320
What this trial is testing

Exparel as a Nerve Block for Severe Hand Pain

Who this might be right for
CREST SyndromePeripheral Vascular DiseaseRaynaud Disease+1 more
Jose Soberon, MD 13
Not applicableStudy completedNCT03094910
What this trial is testing

Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon

Who this might be right for
Raynaud DiseaseRaynaud PhenomenonHand and Arm Vibration Syndrome+5 more
Herlev Hospital 174
Large-scale testing (Phase 3)Study completedNCT00419419
What this trial is testing

Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseSclerodermaAutoimmune Diseases
MediQuest Therapeutics 80
Testing effectiveness (Phase 2)Study completedNCT02260557
What this trial is testing

Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Actelion 74
Not applicableStudy completedNCT03058887
What this trial is testing

The Effects of Exercise in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisRaynaud's PhenomenonQuality of Life
Sheffield Hallam University 36
Not applicableStudy completedNCT00822354
What this trial is testing

Tadalafil for the Treatment of Raynaud's

Who this might be right for
Raynaud
Northwestern University 10
Not applicableStudy completedNCT03699436
What this trial is testing

Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon

Who this might be right for
Raynaud PhenomenonRaynaud Disease
Universidad de Granada 60
Testing effectiveness (Phase 2)Study completedNCT00251238
What this trial is testing

Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon

Who this might be right for
Raynaud Disease
VSM Geneesmiddelen b.v. 41
Testing effectiveness (Phase 2)Study completedNCT03867097
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 34
Large-scale testing (Phase 3)Study completedNCT02050360
What this trial is testing

"As Required" Oral Sildenafil in Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
University Hospital, Grenoble 41
Very early researchStudy completedNCT03027674
What this trial is testing

Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

Who this might be right for
Raynaud Phenomenon Due to TraumaRaynaud DiseaseSystem; Sclerosis+3 more
Pontificia Universidad Catolica de Chile 10
Not applicableStudy completedNCT01233999
What this trial is testing

Botulinum Toxin in the Treatment of Raynaud's

Who this might be right for
Raynaud's Syndrome
Emory University 10
Not applicableStudy completedNCT04854850
What this trial is testing

Apollo Device for Fatigue in Systemic Sclerosis

Who this might be right for
Systemic SclerosisFatigueRaynaud Phenomenon
Robyn T. Domsic, MD, MPH 25
Large-scale testing (Phase 3)Study completedNCT00004786
What this trial is testing

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Systemic SclerosisRaynaud Disease
National Center for Research Resources (NCRR) 200
Large-scale testing (Phase 3)Study completedNCT00351117
What this trial is testing

St. John's Wort in the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Next Page